Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06625112Recruiting

A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders

Role: collaborator

NCT04117178Phase 4Completed

Monitoring Anti-Dementia Drugs by Serum Levels

Role: collaborator

NCT04218812Not ApplicableActive Not Recruiting

Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation

Role: collaborator

NCT04095247Terminated

Does Pulse-triggered VNS Autostimulation Increase VNS Efficacy

Role: collaborator

NCT04171934Completed

Clinical Validation of a Video-based Epilepsy Examination Service

Role: collaborator

NCT04615442Not ApplicableCompleted

ECV - Epihunter Clinical Validation

Role: collaborator

NCT03533374Completed

Validation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With Epilepsy

Role: collaborator

NCT03533530Not ApplicableCompleted

Clinical Utility of ESI in Presurgical Evaluation of Patients With Epilepsy

Role: collaborator

All 8 trials loaded